Effect of Age on the Safety and Efficacy of Selinexor in Patients with Relapsed Refractory Multiple Myeloma: A Post-hoc Analysis of the STORM Study
Year: 2019
Type: article
Authors: Maria Gavriatopoulou, Dan T. Vogl, Ajay Nooka, David Dingli, Craig Cole, Philippe Moreau, Carol Huff, Andrew Yee, Meletios A. Dimopoulos, Sagar Lonial, Paul G. Richardson, Keith Stewart, Ajai Chari, Joshua Richter, Noa Biran, David S. Siegel, Jianjun Liu, Anita Joshi, Jatin Shah, Sharon Shacham, Michael Kauffman, Sundar Jagannath
Institutions: National and Kapodistrian University of Athens, Abramson Cancer Center, University of Pennsylvania, Winship Cancer Institute, Mayo Clinic, U-M Rogel Cancer Center, Centre Hospitalier Universitaire de Nantes, Nantes Université, Johns Hopkins University, Massachusetts General Hospital, Alexandra Hospital, Emory University, Harvard University, Dana-Farber Cancer Institute, Mayo Clinic in Arizona, Icahn School of Medicine at Mount Sinai, Hackensack University Medical Center, Karyopharm Therapeutics (United States), Mount Sinai Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980709024